Clinical and Diagnostic Laboratory Immunology, November 1998, p. 790-798, Vol. 5, No. 6
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Division of Clinical Immunology, Mount Sinai Medical Center, New York, New York 10029
Received 11 May 1998/Returned for modification 23 June 1998/Accepted 23 July 1998
We have developed a novel system to study monocytic function after
human immunodeficiency virus type 1 (HIV-1) infection by infecting a
series of human macrophage hybridoma cell lines with HIV-1. Since
ethanol has detrimental effects on immune function, we investigated the
effect of ethanol and its metabolites acetaldehyde and acetate on
monocytic function by utilizing one human macrophage hybridoma cell
line, clone 43, as well as primary monocytes. Pretreatment of clone 43 and primary monocytes with ethanol and its metabolites resulted in
diminished accessory cell function for mitogen-, anti-CD3-, and
antigen-induced T-cell proliferation. The decreased accessory cell
function was associated with reduced interleukin 1
(IL-1
), IL-1
, and tumor necrosis factor alpha production with loss of intracellular cytokine and mRNA production and the induction of transforming growth factor
. In ethanol-, acetaldehyde-, and acetate-treated HIV-1-infected clone 43 cells (43HIV),
there was a more rapid loss (3 days after infection) of accessory cell
function at a lower infecting dose of HIV-1 than that in untreated
43HIV cells. We also observed a more rapid loss of surface
class II antigen expression in the ethanol-, acetaldehyde-, and
acetate-treated 43HIV cells, but no change in surface
expression of CD80 or CD86. Ethanol-induced impairment of monocytic
function may compound the immunologic defects of AIDS, making the
infected individual more susceptible to the complications of the disease.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |